Mark S. Borja
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- RNA and protein synthesis mechanisms 2
- Protein Interaction Studies and Fluorescence Analysis 2
- RNA modifications and cancer 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Co-authors
- Michael N. Oda (13 shared papers)John D. Gross (2 shared papers)Kirill Piotukh (1 shared paper)Christian Freund (1 shared paper)Stephen N. Floor (1 shared paper)Karen Reue (1 shared paper)Arthur P. Arnold (1 shared paper)Xuqi Chen (1 shared paper)
- Journals
- PLoS ONE (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Journal of Biological Chemistry (2 papers)Experimental Biology and Medicine (1 paper)AIDS (1 paper)
- Partner nations
- United StatesNorwayVietnam
In The Last Decade
Mark S. Borja
18 papers receiving 474 citations
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 151
- Biochemistry 24
- Clinical Biochemistry 25
- Surgery 118
- Emergency Medicine 21
Countries citing papers authored by Mark S. Borja
This map shows the geographic impact of Mark S. Borja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Borja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Borja more than expected).
Fields of papers citing papers by Mark S. Borja
This network shows the impact of papers produced by Mark S. Borja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Borja. The network helps show where Mark S. Borja may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark S. Borja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 81 | |
| 2 | 2013 | 52 | |
| 3 | 2010 | 45 | |
| 4 | 2018 | 45 | |
| 5 | 2015 | 40 | |
| 6 | 2018 | 37 | |
| 7 | 2017 | 31 | |
| 8 | 2012 | 29 | |
| 9 | 2017 | 25 | |
| 10 | 2017 | 17 | |
| 11 | 2013 | 17 | |
| 12 | 2017 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2016 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 6 | |
| 17 | 2024 | 2 | |
| 18 | 2017 | 1 |
About Mark S. Borja
Mark S. Borja is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Emergency Medicine and Biochemistry, having authored 18 papers that have together received 488 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Peroxisome Proliferator-Activated Receptors (3 papers), RNA and protein synthesis mechanisms (2 papers), HIV-related health complications and treatments (2 papers), Protein Interaction Studies and Fluorescence Analysis (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Cholesterol and Lipid Metabolism (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (151 citations), Biochemistry (24 citations), Clinical Biochemistry (25 citations), Surgery (118 citations) and Emergency Medicine (21 citations). Mark S. Borja has collaborated with scholars based in United States, Norway and Vietnam. Frequent co-authors include Michael N. Oda, John D. Gross, Kirill Piotukh, Christian Freund, Stephen N. Floor, Karen Reue, Arthur P. Arnold, Xuqi Chen, Jenny C. Link and Chongren Tang. Their work appears in journals such as PLoS ONE, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Experimental Biology and Medicine and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.